Skip to content

    Announcements

    Exciting News for WebMD Members!

    We've been busy behind the scenes building new message boards for you. You'll have new and easier ways to find messages, connect with others, and share your stories.

    And, this will all be available on your smartphone or other mobile device!

    What Do You Need to Do?

    The message board you're used to will be closing in the coming weeks. While many of your boards will be making the move to our new home, your posts will not. Want to keep a discussion going? Save posts you want to continue (this includes your member profile story), so that you can re-post them in the new message boards.

    Keep an eye here and on your email inbox, we'll be back in touch soon to give you all the information you need!


    Yours in health,
    WebMD Message Boards Management

    New Arthritis Drug Xeljanz Gets FDA Approval
    avatar
    Caprice_WebMD_Staff posted:
    Nov. 6, 2012 -- The FDA has approved Pfizer's Xeljanz (tofacitinib), a first-of-its-kind treatment for rheumatoid arthritis .

    Xeljanz is approved for use by patients not helped by methotrexate , the usual first treatment for RA. It's a pill taken twice a day.

    Xeljanz is a type of drug called a Janus kinase or JAK inhibitor. Blocking JAK mutes the inflammation responses responsible for RA.
    "Xeljanz provides a new treatment option for adults suffering from the debilitating disease of RA who have had a poor response to methotrexate," says Badrul Chowdhury, MD, PhD, the FDA's head of pulmonary, allergy , and rheumatology products.
    We must let go of the life we have planned, so as to accept the one that is waiting for us. ~Joseph Campbell
    Was this Helpful?
    3 of 3 found this helpful
    Reply
     
    avatar
    lex16420 responded:
    @25k a year
     
    avatar
    xperky replied to lex16420's response:
    Yikes


    Helpful Tips

    Dry eyes and dry mouthExpert
    Patients with RA may develop dryness of the eyes and mouth due to a condition called secondary Sjogrens Syndrome. The dryness is due to ... More
    Was this Helpful?
    41 of 48 found this helpful

    Related Drug Reviews

    • Drug Name User Reviews

    Report Problems With Your Medications to the FDA

    FDAYou are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.